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Abstract
Background: Salivary gland tumors (SGT) correspond to a heterogeneous group of lesions with variable biolog-
ical behavior. The present study aimed to determine the distribution and demographic findings of salivary gland 
neoplasms in a northeast Brazilian population.
Material and Methods: A retrospective descriptive cross-sectional study was performed. A total of 588 cases of 
SGT were diagnosed between 2006 and 2016 of 4 pathology services in the state of Sergipe, Brazil. All cases were 
reviewed, and data such as sex, age, anatomical location, and histopathological diagnosis were collected.
Results: A total of 470 (79.9%) tumors were benign and 118 (20.1%) were malignant. The majority of the patients 
were females (n=328, 55.8%) with an overall female:male ratio of 1.2:1. The major salivary glands were affected 
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Introduction
Salivary gland tumors (SGT) are uncommon lesions 
that present a wide variation in relation to the clinical, 
histological, and biological aspects (1,2). In addition, 
these lesions often represent a diagnostic challenge for 
the pathologist due to the overlapping of morphological 
findings (2,3).
SGT account for about 3 to 6% of all tumors in the 
head and neck region, with an annual estimated global 
incidence ranging from 0.4 to 13.5 cases per 100,000 
individuals (2,4). Although several studies evaluate 
the frequency and incidence of these tumors in Brazil 
(1,2,5-10) and other countries of the world (11-16), the 
epidemiological data of these lesions is not well estab-
lished because there is a wide variation in the incidence 
and prevalence of these tumors across countries, indi-
cating a geographic variation in the frequency of these 
neoplasms (2,9).
Thus, the objective of the present study was to describe 
the demographic and clinical aspects of salivary gland 
neoplasms diagnosed in 4 reference pathology centers 
in the state of Sergipe (Aracaju, Brazil), and to compare 
the findings with epidemiological data from different 
geographic locations.
Material and Methods
- Study design
In this study, the files of 4 surgical pathology centers 
in Aracaju, Sergipe State, Brazil were retrospectively 
reviewed: Laboratory of Surgical Pathology of the Uni-
versity Hospital of the Federal University of Sergipe 
(HU-UFS), Oral Pathology Service of the Tiradentes 
University (UNIT), and two private general pathology 
services. During a 10-year period, between January 
2006 and December 2016, 588 cases of salivary gland 
neoplasms were retrieved from these archives. 
- Sample
All cases of salivary gland tumors were retrieved, and 
data such as gender, age,  anatomical location, and his-
topathological diagnosis were obtained from clinical 
records and analyzed. The lesions were classified into 
benign and malignant tumors in accordance with the 
current WHO classification of the head and neck tumors 
(17). Microscopical slides of all cases were examined by 
two independent pathologists with more than 25 years 
of experience. Immunohistochemical and histochemical 
analyses were performed when routine staining (hema-
toxylin-eosin) was not sufficient to establish the final 
diagnosis.
- Analysis
Descriptive and quantitative data analysis was per-
formed using the Statistical Package for the Social 
Sciences for Windows 20.0 (SPSS, Inc., Chicago, IL, 
USA). Continuous variables were expressed as mean, 
median and standard deviation values. Categorical vari-
ables were expressed as absolute number of cases and 
percentage values. Person’s chi-square test and Fisher’s 
exact test were used to evaluate association between 
biological behavior (malignant vs benign tumors) and 
clinical and demographic characteristics, adopting a p-
value of ≤0.05 and a 95% confidence interval.
Results
In a 10-year period [2006-2016], there were 588 salivary 
gland neoplasms diagnosed at the 4 pathology reference 
centers in Aracaju, Sergipe State, Brazil. Of the total 
of 588 cases of salivary gland neoplasms, 470 (79.9%) 
were benign and 118 (20.1%) malignant neoplasms with 
a benign:malignant ratio of 3.9:1, distributed among 7 
benign and 10 malignant histologic subtypes (Table 1).
The majority of patients were female (n=328, 55.8%) 
with an overall female:male ratio of 1.2:1 (Table 1). 
Most tumors occurred in the patients between the third 
and seventh decades of life, with a mean age of 57.9 
years (range 2-106 years). The distribution of each sali-
vary gland neoplasm, according to the age of patients, is 
showed in Table 2.
Regarding the anatomical site, 69.5% of the tumors 
occurred in the major salivary glands (n=363, 69.5%) 
while only 30.5% affected the minor salivary glands. 
The parotid gland was the most commonly affected, 
with a frequency of 51% (n=300), followed by the pal-
ate (n=101, 17.2%), submandibular gland (n=63, 10.7%), 
lips (n=33, 5.6%), buccal mucosa (n=22, 3.7%), and floor 
of the mouth (n=1, 0.2%). There were 66 cases with 
unspecified anatomic location (11.2%), and none tu-
mor affected the sublingual gland (Fig. 1). Both benign 
and malignant neoplasms predominated in the parotid 
gland, followed by the palate and submandibular gland, 
respectively (Table 3).
more than the minor glands (69.5% vs. 30.5%). Pleomorphic adenoma (n=419, 71.3%) and mucoepidermoid carci-
noma (n=29, 4.9%) were the most frequent benign and malignant tumors, respectively. In addition, both benign and 
malignant tumors occurred more frequently in the parotid gland (n=300, 51%, p<0.05).
Conclusions: The epidemiologic profile and clinical characteristics of SGT were similar to those described in other 
countries and other regions of Brazil. Epidemiological studies of SGT help to understand their clinical and patholog-
ical features and are essential to establish the proper management and prognosis.
Key words: Salivary gland, tumors, epidemiology, head and neck pathology.
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n=588 %a %b 
Sex
Male Female
n % n %
Benign tumors
Pleomorphic adenoma 419 71.3 89.1 162 27.6 257 43.7
Warthin’s Tumor 30 5.1 6.4 22 3.7 8 1.4
Canalicular adenoma 6 1.0 1.3 4 0.7 2 0.3
Myoepithelioma 6 1.0 1.3 2 0.3 4 0.7
Basal cell adenoma 4 0.7 0.9 2 0.3 2 0.3
Cystadenoma 3 0.5 0.6 1 0.2 2 0.3
Oncocytoma 2 0.3 0.4 2 0.3 0 0.0
Total 470 79.9 100 195 33.2 275 46.8
Malignant tumors
Mucoepidermoid carcinoma 29 4.9 24.6 14 2.4 15 2.6
Adenocarcinoma NOS 24 4.1 20.3 17 2.9 7 1.2
Adenoid cystic carcinoma 21 3.6 17.8 10 1.7 11 1.9
Polymorphous adenocarcinoma 13 2.2 11.0 5 0.9 8 1.4
Carcinoma ex-PA 10 1.7 8.5 8 1.4 2 0.3
Acinic cell carcinoma 9 1.5 7.6 5 0.9 4 0.7
Epithelial-myoepithelial carcinoma 6 1.0 5.1 3 0.5 3 0.5
Salivary duct carcinoma 3 0.5 2.5 2 0.3 1 0.2
Squamous cell carcinoma 2 0.3 1.7 1 0.2 1 0.2
Myoepithelial carcinoma 1 0.2 0.8 0 0.0 1 0.2
Total 118 20.1 100 65 11.1 53 9.0
a Percent in relation to the total number of cases; b Percent in the group (benign or malignant).
Table 1: Histologic and gender distribution of 588 benign and malignant neoplasms of salivary glands.
Age 
range
Mean 
age a
Age groups Total
0-
20
21
-4
0
41
-6
0
>6
1 NS n %
Benign 
tumors
Pleomorphic adenoma 02-92 43.5 35 160 137 74 13 419 71.3
Warthin’s Tumor 33-81 58.8 0 2 19 9 0 30 5.1
Canalicular adenoma 53-78 67.8 0 0 1 5 0 6 1.0
Myoepithelioma 27-72 51.5 0 1 3 2 0 6 1.0
Basal cell adenoma 48-61 57.0 0 0 3 1 0 4 0.7
Cystadenoma 48-61 57.0 0 0 2 1 0 3 0.5
Oncocytoma 51-57 54.0 0 0 2 0 0 2 0.3
Malignant 
tumors
Mucoepidermoid carcinoma 11-106 47.0 4 7 10 8 0 29 4.9
Adenocarcinoma NOS 26-88 57.6 0 4 10 10 0 24 4.1
Adenoid cystic carcinoma 29-82 57.1 0 3 8 10 0 21 3.6
Polymorphous adenocarcinoma 37-78 58.2 0 1 5 7 0 13 2.2
Carcinoma ex-PA 38-77 60.4 0 1 3 6 0 10 1.7
Acinic cell carcinoma 20-69 47.8 1 1 6 1 0 9 1.5
Epithelial-myoepithelial carcinoma 59-100 78.2 0 0 2 4 0 6 1.0
Salivary duct carcinoma 52-74 60.3 0 0 2 1 0 3 0.5
Squamous cell carcinoma 74-83 78.5 0 0 0 2 0 2 0.3
Myoepithelial carcinoma 49 49.0 0 0 1 0 0 1 0.2
NS: not specified; a Years.
Table 2: Age group distribution (decade of life) of benign and malignant salivary gland tumors.
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Fig. 1: Distribution of 588 salivary gland tumors according to the 
primary site of involvement. NS, not specified.
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Pleomorphic adenoma 215 54 0 56 26 18 1 0 49 419 71.3
Warthin’s Tumor 25 2 0 0 0 0 0 0 3 30 5.1
Canalicular adenoma 0 0 0 1 4 1 0 0 0 6 1.0
Myoepithelioma 1 0 0 4 0 0 0 0 1 6 1.0
Basal cell adenoma 4 0 0 0 0 0 0 0 0 4 0.7
Cystadenoma 1 0 0 1 0 0 0 1 0 3 0.5
Oncocytoma 2 0 0 0 0 0 0 0 0 2 0.3
Total 248 56 0 62 30 19 1 1 53 470 79.9
% 52.8 11.9 0 13.2 6.4 4 0.2 0.2 11.3
M
al
ig
na
nt
 tu
m
or
s
Mucoepidermoid carcinoma 8 1 0 16 0 0 1 0 3 29 4.9
Adenocarcinoma NOS 17 2 0 2 0 1 0 0 2 24 4.1
Adenoid cystic carcinoma 6 3 0 9 0 0 0 0 3 21 3.6
Polymorphous adenocarcinoma 3 0 0 4 3 1 0 0 2 13 2.2
Carcinoma ex-PA 3 0 0 6 0 0 0 0 1 10 1.7
Acinic cell carcinoma 5 0 0 1 0 1 0 0 2 9 1.5
Epithelial-myoepithelial carcinoma 5 1 0 0 0 0 0 0 0 6 1.0
Salivary duct carcinoma 2 0 0 1 0 0 0 0 0 3 0.5
Squamous cell carcinoma 2 0 0 0 0 0 0 0 0 2 0.3
Myoepithelial carcinoma 1 0 0 0 0 0 0 0 0 1 0.2
Total 52 7 0 39 3 3 1 0 13 118 20.1
% 44.1 5.9 0 33.1 2.5 2.5 0.8 0 11
NS: not specified.
Table 3: Distribution of the 588 salivary gland tumors according to the location (major and minor salivary glands).
Among the benign salivary gland tumors, pleomor-
phic adenoma (PA) was most frequent (n=419; 89.1%) 
followed by Warthin’s tumor (n=30, 6.4%), canalicular 
adenoma (n=6, 1.3%) and myoepithelioma (n=6, 1.3%) 
(Table 1). These tumors were diagnosed mainly between 
the fourth and fifth decades of life (Fig. 2); however, the 
age ranged from 2 to 92 years, with an average age of 
55.7 years (SD±7.4) (Table 2).
Fig. 2: Distribution of 588 salivary gland tumors according 
to the age group (decade of life).
Most cases occurred in the parotid gland (n=248, 
52.8%) and female patients (n=275; 58.5%), with a 
female:male ratio of 1.4:1 (275 female and 195 male). 
Regarding the malignancies, mucoepidermoid carci-
noma was the most frequent malignant tumor (n=29, 
24.6%), followed by adenocarcinomas not otherwise 
specified (n=24, 20.3%), and adenoid cystic carcino-
ma (n=21, 17.8%) (Table 1). The age ranged from 11 
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to 106 years, with a mean age of 59.4 years (SD±11.1) 
(Table 2). Most cases also occurred in the parotid 
gland (n=52, 44.1 %) and male (n=65; 55.1%), with a 
female:male ratio of 0.8:1.0 (53 female and 65 male) 
(Table 3).
When the behavior of the tumors (malignant vs be-
nign tumors) was evaluated, the parotid was the most 
affected gland mainly by benign tumors (p<0.05). 
Also, the benign salivary gland tumors were more 
common in female patients (p<0.05); results were 
statistically significant (Table 4).
Discussion
In the last two decades [1999-2019] several studies per-
formed worldwide have been published on the epidemi-
ology of salivary gland neoplasms, as shown in Fig. 3. 
According to the WHO [2017], overall, female patients 
are slightly more affected by salivary gland neoplasms 
than male patients (17). However, some variations 
can be found when analyzing specific tumor subtypes 
(2,9,17,18). In the present study, the female-to-male ra-
tio was 1.2:1, which is in agreement with most studies 
(19,20), including Brazilian reports (2,6,8,9).
Benign Malignant Total P valuen % n % n %
Anatomic site
Parotid 248 82.7 52 17.3 300 51.0
0.0021 a
Submandibular 56 88.9 7 11.1 63 10.7
Minor salivary glands 113 71.1 46 28.9 159 27.0
NI 53 80.3 13 19.7 66 11.2
Gender Female 275 83.8 53 16.2 328 55.8 0.0094 b
Male 195 75.0 65 25 260 44.2
Age
19 ≤ 35 87.5 5 12.5 40 6.8
0.2278 b≥ 20 422 78.9 113 21.1 535 91.0
NI 13 100 0 0 13 2.2
NI: Not informed; %: Percentage; a Pearson’s Chi-square test; b Fisher’s exact test.
Table 4: Anatomic site, gender, and age group distribution of benign and malignant salivary gland tumors.
Fig. 3: World distribution of 37.205 cases of SGT reported in the literature in the last 20 years [1999-2019].
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In addition, benign neoplasms presented a male-to-fe-
male ratio of 1:1.4, while malignant neoplasms demon-
strated a male-to-female ratio of 1:0.8, indicating that 
benign tumors were more common in female patients, 
whereas malignancies were slightly more common in 
males. These data are in accordance with several previ-
ous studies (2,9). However, a previous study performed 
in Mexico showed that female patients were more af-
fected by malignant neoplasms than male patients (21).
In the present study, most tumors were benign (79.9%), 
data similar to other studies where these tumors corre-
spond to about 51.5 to 86.4% of all salivary gland neo-
plasms (2,5-9,13). However, some studies conducted on 
the African (22,23) and Asian continents (24,25) have 
shown a higher incidence of malignancies, and suggest 
geographic variation in the frequency of these tumors.
Regarding the benign neoplasms, pleomorphic ad-
enoma was the most common tumor in this study, ac-
counting for 89.1% of all benign neoplasms followed by 
Warthin’s Tumor (6.4%). In fact, pleomorphic adenoma 
is the most common benign neoplasm in all previous-
ly published studies (1,2,4,5-16,18-30), and Warthin’s 
Tumor was the second benign tumor more frequent 
(1,5,6,8-10). However, some studies have shown basal 
cell adenoma (2,26) or myoepithelioma (23,24,27-30) as 
the second most common benign tumors.
On the other hand, Silva et al. (2) performed a retro-
spective multicentric study in Brazil and observed that 
basal cell adenoma and cystadenoma were the second 
and third most common neoplasms, respectively, dif-
ferent from most studies published in Brazil that shows 
the Whartin’s Tumor as the second most common be-
nign neoplasm (1,5,6,8-10). These results suggest that 
multicenter studies can better characterize the hetero-
geneity of tumors in large territories, such as Brazil, 
for example, and contribute to the comprehension of 
epidemiological differences in the population (2). Also, 
the fact that this study was performed in oral pathol-
ogy services may explain this apparent difference. The 
Warthin’s Tumor is a neoplasm that affects almost ex-
clusively the parotid gland, and some studies show that 
most cases from surgical pathology centers affect the 
major salivary glands, particularly the parotid gland, 
whereas tumors of the minor salivary glands represent 
the majority of cases diagnosed in oral pathology ser-
vices (9). In addition, some other benign tumors, such 
as oncocytomas, were diagnosed in our study (n = 2, 
0.3%). However, these tumors are very rare and are usu-
ally observed only in large sample studies (2).
The most common malignant tumor was the mucoepi-
dermoid carcinoma, accounting for 24.6% of the cases, 
followed by adenocarcinomas not otherwise specified 
(AcNOS), which represented 20.3%, and cystic ad-
enoid carcinoma (17.8%), that corroborate with previ-
ous studies (12-15,19,24-26,29,30). On the other hand, 
other studies indicate cystic adenoid carcinoma as the 
most frequent malignant tumor (1,4,7,8,11,21-23,28). In 
general, the four most frequent malignant tumors are 
mucoepidermoid carcinoma, cystic adenoid carcinoma, 
acinar cell carcinoma, and AcNOS.
The morphological diagnosis of salivary gland tumors 
is challenging due to a large number of histological 
subtypes, overlapping of morphological findings, and 
different classifications (2,3). The diagnosis of poly-
morphous adenocarcinoma, in particular, can be dif-
ficult, especially in pathology centers without an expe-
rienced pathologist in oral and maxillofacial lesions, 
since this tumor shares some morphological charac-
teristics with several other tumors (2). In our study, 
13 cases of polymorphous adenocarcinomas were di-
agnosed, of which 8 affected minor intraoral salivary 
glands, 3 affected parotid glands, and 3 cases with 
unspecified anatomical sites. This strong predilection 
for polymorphic adenocarcinoma by minor salivary 
glands, especially in the palate region, is well estab-
lished in the literature (17). Furthermore, until the last 
WHO classification, polymorphous adenocarcinoma 
was called “low-grade polymorphous adenocarcino-
ma”, because in most cases, it exhibits indolent behav-
ior. However, approximately 10% to 33% of patients 
develop local recurrences, 9% to 15% have nodal me-
tastases, and some cases are extremely aggressive, 
with imprecise clinical behavior (2). Considering the 
variation in the biological behavior of these lesions, 
the new classification proposed by the WHO for sali-
vary gland neoplasms abandoned the term “low grade” 
and renamed these tumors only as polymorphous ad-
enocarcinoma (2,17). The purpose of this modification 
is to avoid possible terminological confusion and to 
facilitate the choice of treatment, especially for the 
most unusual cases (2,17). In addition, in our study, 
some other malignant tumors were very rare, such as 
salivary duct carcinomas (n=3, 0.5%) and myoepithe-
lial carcinomas (n=1, 0.2%). Although these entities 
are well recognized, they are also rarely reported in 
studies with small samples (2).
Regarding the anatomical location, most of the SGTs 
of this study were diagnosed in the parotid gland, fol-
lowed by the minor salivary glands of the palate and 
submandibular gland. In general, this result was also 
reported by other studies (1,4,9,11,14,15,19,20,23,26). 
However, some studies have shown that malignant neo-
plasms preferentially affect the minor intraoral salivary 
glands (1,2,9).
In summary, although several studies evaluate the fre-
quency and incidence of salivary gland neoplasms, con-
tinuous studies that report the incidence and character-
istics of these lesions are essential to keep physicians 
and surgeons up to date, especially when the classifica-
tion of these tumors undergoes some change (2).
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Conclusions
The results of this study were similar to those found 
by several other authors in Brazil and worldwide. The 
pleomorphic adenoma was the most common benign tu-
mor, and the mucoepidermoid carcinoma the most fre-
quent malignant tumor in the salivary glands. In addi-
tion, both benign and malignant tumors occurred more 
frequently in the parotid gland.
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